Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ C4443037!4443037!26064203     free     free     free       Int+J+Clin+Exp+Med 2015 ; 8 (3): 3136-40 Nephropedia Template TP {{tp|p=26064203|t=2015. FoxM1: a novel tumor biomarker of lung cancer |pdf=|usr=}}{{26064203}} gab.com Text FoxM1: a novel tumor biomarker of lung cancer JO: Int J Clin Exp Med http://www.kidney.de/pget.php?&tw=1&pmid=26064203 #FOAvip FoxM1 is a member of the Forkhead box (Fox) family of transcription factors, which is expressed in actively dividing cells and is critical for cell cycle progression. Increased expression of FoxM1 was found in many tumors including non-small cell lung cancer (NSCLC). A more recent study showed FoxM1 is associated with poor prognosis of NSCLC patients through promoting tumor metastasis; elucidated FoxM1 could exert a direct effect on the prognosis of NSCLCs patients. In this review, we summarize the role FoxM1 in lung cancer in the hope of providing insights into the utility of FoxM1 as a novel biomarker of lung cancer. Twit Text FOAVip FoxM1: a novel tumor biomarker of lung cancer ????Int J Clin Exp Med http://www.kidney.de/pget.php?&tw=1&pmid=26064203 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26064203 #FOAvip English Wikipedia <ref>{{Cite pmid|26064203}}</ref> FoxM1: a novel tumor biomarker of lung cancer #MMPMID26064203 Zhang J; Zhang J; Cui X; Yang Y; Li M; Qu J; Li J; Wang J Int J Clin Exp Med 2015[]; 8 (3): 3136-40 PMID26064203show ga FoxM1 is a member of the Forkhead box (Fox) family of transcription factors, which is expressed in actively dividing cells and is critical for cell cycle progression. Increased expression of FoxM1 was found in many tumors including non-small cell lung cancer (NSCLC). A more recent study showed FoxM1 is associated with poor prognosis of NSCLC patients through promoting tumor metastasis; elucidated FoxM1 could exert a direct effect on the prognosis of NSCLCs patients. In this review, we summarize the role FoxM1 in lung cancer in the hope of providing insights into the utility of FoxM1 as a novel biomarker of lung cancer. äFoxM1: a novel tumor biomarker of lung cancer (epmc).pdf DeepDyve Pubget Overpricing